Seneca House Advisors Bristol Myers Squibb CO Transaction History
Seneca House Advisors
- $230 Million
- Q1 2025
A detailed history of Seneca House Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seneca House Advisors holds 4,329 shares of BMY stock, worth $222,250. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,329
Previous 4,416
1.97%
Holding current value
$222,250
Previous $249,000
6.02%
% of portfolio
0.11%
Previous 0.1%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,775Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.75 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.15 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.93 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.88 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.1 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $109B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...